WomenCan fundraises to support clinical trials conducted by ANZGOG, a world leader in gynaecological cancer research.
ANZGOG’s Fund for New Research program's purpose is to promote the development of future clinical trials and foster its member’s research studies.
In the past, grants have been funded by individual fundraisers who wished to fundraise for a particular cancer type or geographical area, leaving a lasting legacy to benefit women in the future.
Fund for New Research grants are reviewed by research leaders and adopted as novel and innovative ideas warranting further work, individual grants of up to $100,000 are awarded annually for pre-clinical, pilot and feasibility studies that lead to a clinical trial. Research must be achievable and meet ANZGOG’s strategic research priorities.
In the recent 2022 round, 15 applications were received and two projects were awarded grants of up to $100,000 each.
ANZGOG member, PI Prof Sarah-Jane Dawson will be awarded $100,000 for her clinical concept – ‘ctDNA analysis in advanced endometrial cancer following single-agent PD-L1 antibody therapy: a translational research sub-study of the PHAEDRA trial’.
ANZGOG member, PI Dr Tania Moujaber will be awarded $99,938 for her Pre-clinical concept – ‘testing of combined MEK and CDK4/6 inhibition for low-grade serous ovarian cancer’.
Want to learn more about funding pioneering research?
The Fund for New Research was seed-funded by philanthropy and continues to seek private and public donations for innovative research projects in all gynaecological cancers. Foster innovation with your gift. Support pioneering research projects that have the capability to lead to a significant clinical trial.
To find out more about ANZGOG's Fund for New Research Program, click on the button below: